<?xml version="1.0" encoding="UTF-8"?>
<fig id="molecules-25-05514-f003" orientation="portrait" position="float">
 <label>Figure 3</label>
 <caption>
  <p>Antileishmanial effect of the essential oil from 
   <italic>Melaleuca leucadendra</italic> collected in National Botanic Garden, Havana, Cuba, on BALB/c mice infected with 5 × 10
   <sup>6</sup> promastigotes of 
   <italic>L. amazonensis</italic>/animal. Treatment started four weeks post-infection with essential oil from 
   <italic>Melaleuca leucadendra</italic> or Glucantime
   <sup>®</sup> with five doses by the intralesional route at 30 mg/kg every four days. (
   <bold>A</bold>): Lesion size; (
   <bold>B</bold>): Parasite burden; (
   <bold>C</bold>): Pictures at 12 weeks post-infection of infected animals in the footpad with 
   <italic>L. amazonensis</italic> and treated. EO-ML: essential oil from 
   <italic>M. leucadendra</italic>; GTM: Glucantime
   <sup>®</sup> used as reference drug; Control: Untreated animals. *: Displays statistical differences (
   <italic>p</italic> &lt; 0.05) compared to control untreated animals.
  </p>
 </caption>
 <graphic xlink:href="molecules-25-05514-g003" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
